Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and bla CTX-M-15among extended-spectrum-β- lactamase-producing E. coli from the United States, 2000 to 2009

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2364-2370

  Johnson, James R ^a,b   Urban, Carl ^c,d   Weissman, Scott J ^e   Jorgensen, James H ^f   Lewis II, James S ^f   Hansen, Glen ^b,g   Edelstein, Paul H ^h   Robicsek, Ari ⁱ   Cleary, Timothy ^j   Adachi, Javier ^k   Paterson, David ^l,m   Quinn, John ^n,o   Hanson, Nancy D ^p   Johnston, Brian D ^a,b   Clabots, Connie ^b   Kuskowski, Michael A ^a,b   Bergsbaken, Robert L ^q   Hooton, Thomas M ^r   Hulse, Michelle ^j   Lolans, Karen ^s   Owens, Rob ^t   Palavecino, Elizabeth ^u   Vigil, Karen ^v   more..

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c NEW YORK HOSPITAL QUEENS   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY HEALTH SYSTEM   (United States)

^g HENNEPIN COUNTY MEDICAL CENTER   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^j UNIVERSITY OF MIAMI   (United States)

^k UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^l UNIVERSITY OF PITTSBURGH   (United States)

^m UNIVERSITY OF QUEENSLAND   (Australia)

ⁿ Chicago Infectious Disease Research Institute   (United States)

^o PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^p CREIGHTON UNIVERSITY   (United States)

^q Health Partners and Regions Medical Center   (United States)

^r Children's Hospitals   (United States)

^s RUSH UNIVERSITY   (United States)

^t Cubist Pharmaceuticals   (United States)

^u WAKE FOREST UNIVERSITY   (United States)

^v UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE CTX M; QUINOLONE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; ESCHERICHIA COLI; ESCHERICHIA COLI O25:H4; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; GENOTYPE; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; PULSED FIELD GEL ELECTROPHORESIS; REPRODUCIBILITY; UNITED STATES;

ADULT; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HUMANS; LONGITUDINAL STUDIES; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; UNITED STATES; VIRULENCE;

EID: 84860204494     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05824-11     Document Type: Article

References (30)

1. Clermont O, Bonacorsi S, Bingen E. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
2. Clermont O, et al. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
3. Clermont O, et al. 2008. The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J. Antimicrob. Chemother. 61:1024-1028. (Pubitemid 351524443)
4. Clinical Laboratory Standards Institute. 2009. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement (M100-S19). Clinical Laboratory Standards Institute, Wayne, PA.
5. Coque TM, Novais Â, et al. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTXM-15. Emerg. Infect. Dis. 14:195-200. (Pubitemid 351213667)
6. Ender PT, et al. 2009. Transmission of extended-spectrum-beta-lactamase- producing Escherichia coli (sequence type ST131) between a father and daughter resulting in septic shock and emphysematous pyelonephritis. J. Clin. Microbiol. 47:3780-3782.
7. Johnson JR, Anderson JT, Clabots C, Johnston B, Cooperstock M. 2010. Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection. Pediatr. Infect. Dis. J. 29:473-475.
8. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States (2007). Clin. Infect. Dis. 51:286-294.
9. Johnson JR, et al. 2010. Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients. Antimicrob. Agents Chemother. 54:546-550.
10. Johnson JR, et al. 2009. Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob. Agents Chemother. 53:2733-2739.
11. Johnson JR, Miller S, Johnston B, Clabots C, Debroy C. 2009. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and urovirulent E. coli strains among dogs and cats within a household. J. Clin. Microbiol. 47:3721-3725.
12. Johnson JR, et al. 2003. Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products. Antimicrob. Agents Chemother. 47:2161-2168. (Pubitemid 36753567)
13. Johnson JR, Stell AL. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272. (Pubitemid 30049057)
14. Johnson L, et al. 2008. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am. J. Med. 121:876-884.
15. Leflon-Guibout V, et al. 2004. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob. Agents Chemother. 48:3736-3742. (Pubitemid 39304597)
16. Lewis JS, II, Herrera M, Wickes B, Patterson JE, Jorgensen JH. 2007. First report of the emergence of CTX-M-type extended-spectrum betalactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Antimicrob. Agents Chemother. 51:4015-4021. (Pubitemid 350057800)
17. McGettigan SE, Hu B, Andreacchio K, Nachamkin I, Edelstein PH. 2009. Prevalence of CTX-M beta-lactamases in Philadelphia, Pennsylvania. J. Clin. Microbiol. 47:2970 -2974.
18. Nicolas-Chanoine M-H, et al. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273-281.
19. Peakall R, Smouse PE. 2006. GENALEX 6: genetic analysis in Excel. Population genetic software for teaching and research. Mol. Ecol. Notes 6:288-295. (Pubitemid 43373825)
20. Peirano G, Costello M, Pitout JDD. 2010. Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents 36:19-23.
21. Peirano G, Pitout JDD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316-321.
22. Pitout JD. 2012. Extraintestinal pathogenic Escherichia coli: a combination of virulence with antibiotic resistance. Front. Microbiol. 3:9.
23. Pitout JD, Nordmann P, Laupland KB, Poirel L. 2005. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59. (Pubitemid 41418336)
24. Ribot EM, et al. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67.
25. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b- ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
26. Russo TA, Johnson JR. 2003. Medical and economic impact of extraintestinal infections due to Escherichia coli: an overlooked epidemic. Microbes Infect. 5:449-456. (Pubitemid 36549187)
27. Sidjabat HE, et al. 2009. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob. Agents. Chemother. 53:4733-4739.
28. Tenover FC, et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
29. Urban C, et al. 2010. Identification of CTX-M β-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities. Diagn. Microbiol. Infect. Dis. 66:402-406.
30. Vigil KJ, et al. 2009. Escherichia coli pyomyositis: an emerging entity among patients with hematologic malignancies. Clin. Infect. Dis. 50:374-380.